USP Seeks Experts for 2015-2020 Council of Experts - - BioPharm International

ADVERTISEMENT

USP Seeks Experts for 2015-2020 Council of Experts



The U.S. Pharmacopeial Convention (USP) has announced its call for candidates for the 2015–2020 Council of Experts, USP’s scientific decision-making body.

USP’s Council of Experts is responsible for developing and revising standards that are included in USP’s seven compendia: The United States Pharmacopeia and the National Formulary; Medicines Compendium; USP on Compounding; Herbal Medicines Compendium; Dietary Supplements Compendium; and Food Chemicals Codex.

Currently more than 30% of the Council’s members comprise experts from outside of the US. The 2015–2020 Council of Experts includes 26 Expert Committees, six of which will meet outside of the US. All Expert Committees are supported by USP’s international site and Rockville, Maryland headquarters staff. The 2015–2020 Council of Experts will benefit from USP’s network of laboratories, which includes over 170,000 square feet of laboratory resources and a global staff located in the US, India, China, and Brazil.

The Council of Experts is elected every five years at the meeting of the USP Convention, with the next meeting to take place in April 2015. New experts will begin their five-year tenure on July 1, 2015. Members of the Council of Experts serve as chairs of USP’s Expert Committees, each of which addresses a specific standards-setting area within USP. Theseareas include chemical medicines, biologic medicines, excipients, compounded preparations, dietary supplements, and food ingredients. USP is also seeking candidates to serve as members of Expert Committees.

Candidates may nominate themselves or a colleague at http://uspgo.to/c

Source: USP

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
AbbVie's Acquisition of Shire Could Save $8 Billion in Taxes
July 21, 2014
AstraZeneca Reveals Design for New Global R&D Center and Corporate Headquarters
July 18, 2014
AbbVie to Acquire Shire for $54.7 Billion
July 18, 2014
Particulate Matter Prompts Baxter's Recall of IV Solutions
July 17, 2014
Author Guidelines

Click here